Albany, NY, March 21, 2016 -- The research report, titled “Pharmacovigilance Market (Phases of Drug Development: Preclinical Studies, Clinical Trial Phase I, II, III & IV or Post Marketing Surveillance; Type of Methods: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, & EHR Mining; Type of Service: In-House & Contract Outsourcing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, states that the overall value of the worldwide pharmacovigilance market stood at US$2.4 bn in 2013.
According to the report, the rising incidence of adverse drug reactions and drug toxicity is fueling the demand for pharmacovigilance activities across the world.
For more info, get a Sample PDF: http://www.researchmoz.us/enquiry.php?type=S&repid=479362
The global pharmacovigilance market is segmented on the basis of phase of drug development, method, and service in this research report. Preclinical studies, phase one, phase two, phase three, and post market surveillance are the main phases of drug development. Spontaneous reporting, targeted spontaneous reporting, intensified ADR reporting, cohort event monitoring, and EHR mining are the major methods applied for pharmacovigilance. In-house and contract outsourcing services are the key types of services offered in this market.
On the regional front, the global pharmacovigilance market has been analyzed on the basis of its performance in North America, Asia Pacific, Europe, and the Rest of the World. North America leads the global market among these. In 2013, it accounted for a share of 35% in the overall market. The increase in clinical research activities, coupled with the abundant presence of large-scale research facilities in this region, is the key factor driving the North America pharmacovigilance market.
Asia Pacific, On the other hand, has been anticipated to register the fastest growth at a CAGR of more than 13% during the forecast period. The large pool of skilled workers and the competitive market is likely to fuel the Asia Pacific pharmacovigilance market in the coming years. In addition to this, the rising number of initiatives by various governments in this region, focused on spreading awareness regarding safety and efficiency of drugs, is projected to stimulate the pharmacovigilance market in Asia Pacific extensively over the forecast period, says the market report.
Browse Report description and TOC:
http://www.researchmoz.us/global-pharmacovigilance-industry-2015-market-research-report-report.html
The report states that the global market for pharmacovigilance is highly fragmented in nature. Accenture plc, Clinquest Group B.V., Bristol-Myers Squibb, Cognizant Technology Solutions, F. Hoffmann-La Roche Ltd., Covance Inc., GlaxoSmithKline plc, iGATE Corp., ICON plc, iMEDGlobal Corp., Novartis International AG, inVentiv Health Inc., PAREXEL International Corp., Pharmaceutical Product Development LLC., Pfizer Inc., PRA Health Sciences Inc., Sanofi, Quintiles Transnational Holdings Inc., Wipro Ltd., and Synowledge LLC are the key players operating in the worldwide pharmacovigilance market.
Related Reports:-
Global Pharmacovigilance Market 2014-2020
In terms of regional analysis, the global pharmacovigilance market has been segmented into four key geographies: North America, Europe, Asia Pacific, and Rest of World (RoW). Market revenue estimations for each of these geographies have been provided in the report for the period from 2012 to 2020 in terms of USD million, considering 2013 as the base year for calculations and 2012 as the historical year. The CAGR (%) of each market segment for the forecast period from 2014 to 2020 has also been provided along with market size estimations.
Browse Full Report:
About Us
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Mr.Nachiket Ghumare State Tower, 90 State Street, Suite 700, Albany NY – 12207 United States Tel: +1-518-621-2074 USA - Canada Toll Free: 866-997-4948 Website: http://www.researchmoz.us/


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Anta Sports Expands Global Footprint With Strategic Puma Stake
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



